Acute leukemia in children with Down's syndrome: The importance of population based study

Haematologica

Volumn 93, Issue 8, 2008, Pages 1262-1263

  James, Rebecca M ^a,b   Lightfoot, Tracy ^a   Simpson, Jill ^a   Moorman, Anthony V ^c   Roman, Eve ^a   Kinsey, Sally ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Acute leukemia; Acute myeloid leukemia; Down's syndrome; Myelodysplasia; Myeloproliferative disorders

Indexed keywords

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; CANCER INCIDENCE; CASE CONTROL STUDY; CHILD; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; CYTOGENETICS; DOWN SYNDROME; HUMAN; LETTER; MAJOR CLINICAL STUDY; NEWBORN; POPULATION RESEARCH; PRE B LYMPHOCYTE;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; GREAT BRITAIN; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 48749091565     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12831     Document Type: Letter

References (11)

1. Hill DA, Gridley G, Cnattingius S, Mellemkjaer L, Linet M, Adami HO, et al. Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med 2003;163: 705-11.
2. Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 2000;355:165-9.
3. Zeller B, Gustafsson G, Forestier E, Abrahamsson J, Clausen N, Heldrup J, et al. Acute leukaemia in children with Down syndrome: a population-based Nordic study. Br J Haematol 2005;128:797-804.
4. UK Childhood Cancer Study Investigators. The United Kingdom Childhood Cancer Study: objectives, materials and methods. UK Childhood Cancer Study Investigators. Br J Cancer 2000;82:1073-102.
5. Lange BJ, Kobrinsky N, Barnard DR, Arthur DC, Buckley JD, Howells WB, et al. Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891. Blood 1998;91:608-15.
6. Creutzig U, Ritter J, Vormoor J, Ludwig WD, Niemeyer C, Reinisch I, et al. Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group. Leukemia 1996;10:1677-86.
7. Whitlock JA, Sather HN, Gaynon P, Robison LL, Wells RJ, Trigg M, et al. Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study. Blood 2005;106: 4043-9.
8. Forestier E, Izraeli S, Beverloo B, Haas O, Pession A, Michalova K, et al. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome - an iBFM-SG study. Blood 2008;111:1575-83.
9. Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, Le Beau MM, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet 2002;32:148-52.
10. Hasle H, Niemeyer CM, Chessells JM, Baumann I, Bennett JM, Kerndrup G, et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003;17:277-82.
11. Rao A, Hills RK, Stiller C, Gibson BE, de Graaf SS, Hann IM, et al. Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials. Br J Haematol 2006;132:576-83.